Author

Mei Mei Hu

Observed names: Hu, Mei Mei, Mei Hu

Institutions: United Biomedical (United States), Sichuan Center for Disease Control and Prevention

Observed institutions: United Biomedical (United States), Sichuan Center for Disease Control and Prevention

OpenAlex ID: A5036076099

A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2

2022 · Shixia Wang, Chang Yi Wang, et al. · Emerging Microbes & Infections · 33

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine (Sinopharm BBIBP-CorV) coadministered with quadrivalent split-virion inactivated influenza vaccine and 23-valent pneumococcal polysaccharide vaccine in China: A multicentre, non-inferiority, open-label, randomised, controlled, phase 4 trial

2022 · Haiping Chen, Zhuoying Huang, et al. · Vaccine · 29

High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster

2022 · Farshad Guirakhoo, Shixia Wang, et al. · The Journal of Infectious Diseases · 28

Potent Anti-Delta Effect By a Booster Third-Dose of UB-612, a Precision-Designed SARS-CoV-2 Multitope Protein-Peptide Vaccine

2021 · Chang Yi wang, Kao-Pin Hwang, et al. · Research Square · 1

La revolución médica: ¿una vacuna contra el Alzheimer?

2018 · Mei Mei Hu · Executive excellence: la revista de liderazgo, la gestión y la toma de decisiones

Works count: 6

Citation count: 91

H-index: 3

I10-index: 3